APA (7th ed.) Citation

JT, T., JM, K., MKC, L., V, C., LM, W., GH, J., . . . DF, S. (2021). Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(1), 150. https://doi.org/10.1158/1078-0432.CCR-20-2831

Chicago Style (17th ed.) Citation

JT, Topham, et al. "Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 27, no. 1 (2021): 150. https://doi.org/10.1158/1078-0432.CCR-20-2831.

MLA (9th ed.) Citation

JT, Topham, et al. "Subtype-Discordant Pancreatic Ductal Adenocarcinoma Tumors Show Intermediate Clinical and Molecular Characteristics." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 27, no. 1, 2021, p. 150, https://doi.org/10.1158/1078-0432.CCR-20-2831.